These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 29655833)

  • 1. Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus.
    Cotton CC; Haidry R; Thrift AP; Lovat L; Shaheen NJ
    Gastroenterology; 2018 Aug; 155(2):316-326.e6. PubMed ID: 29655833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial.
    Cotton CC; Wolf WA; Overholt BF; Li N; Lightdale CJ; Wolfsen HC; Pasricha S; Wang KK; Shaheen NJ;
    Gastroenterology; 2017 Sep; 153(3):681-688.e2. PubMed ID: 28579538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
    Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
    Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
    Wani S; Rubenstein JH; Vieth M; Bergman J
    Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timeline and location of recurrence following successful ablation in Barrett's oesophagus: an international multicentre study.
    Sami SS; Ravindran A; Kahn A; Snyder D; Santiago J; Ortiz-Fernandez-Sordo J; Tan WK; Dierkhising RA; Crook JE; Heckman MG; Johnson ML; Lansing R; Ragunath K; di Pietro M; Wolfsen H; Ramirez F; Fleischer D; Wang KK; Leggett CL; Katzka DA; Iyer PG
    Gut; 2019 Aug; 68(8):1379-1385. PubMed ID: 30635408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic eradication therapy for Barrett's esophagus-related neoplasia: a final 10-year report from the UK National HALO Radiofrequency Ablation Registry.
    Wolfson P; Ho KMA; Wilson A; McBain H; Hogan A; Lipman G; Dunn J; Haidry R; Novelli M; Olivo A; Lovat LB;
    Gastrointest Endosc; 2022 Aug; 96(2):223-233. PubMed ID: 35189088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia.
    Kahn A; Al-Qaisi M; Kommineni VT; Callaway JK; Boroff ES; Burdick GE; Lam-Himlin DM; Temkit M; Vela MF; Ramirez FC
    Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29036431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry.
    Haidry RJ; Dunn JM; Butt MA; Burnell MG; Gupta A; Green S; Miah H; Smart HL; Bhandari P; Smith LA; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Novelli M; Banks MR; Lovat LB
    Gastroenterology; 2013 Jul; 145(1):87-95. PubMed ID: 23542069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance After Treatment of Barrett's Esophagus Benefits Those With High-Grade Dysplasia or Intramucosal Cancer Most.
    Cotton CC; Shaheen NJ; Thrift AP
    Am J Gastroenterol; 2022 Jul; 117(7):1056-1062. PubMed ID: 35435856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
    Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
    Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid nitrogen spray cryotherapy for eradication of dysplastic Barrett's esophagus: results from a multicenter prospective registry.
    Eluri S; Cotton CC; Kaul V; McKinley M; Pleskow D; Nishioka N; Hoffman B; Nieto J; Tsai F; Coyle W; Kothari S; Joshi V; Dumot J; Greenwald B; Habr FG; Shaheen NJ
    Gastrointest Endosc; 2024 Aug; 100(2):200-209. PubMed ID: 38272279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Incidence of Intestinal Metaplasia and Dysplasia of Gastric Cardia in Patients With Barrett's Esophagus After Endoscopic Therapy.
    Eluri S; Earasi AG; Moist SE; Dellon ES; Shaheen NJ
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):82-88.e1. PubMed ID: 31077822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis.
    Sawas T; Alsawas M; Bazerbachi F; Iyer PG; Wang KK; Murad MH; Katzka DA
    Gastrointest Endosc; 2019 May; 89(5):913-925.e6. PubMed ID: 30529044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-focal dysplasia is associated with high recurrence rates after successful ablation of dysplastic Barrett's esophagus.
    Sapoznikov B; Fisch G; Shamah S; Shinhar N; Benjaminov F; Levi Z; Peleg N
    Dig Liver Dis; 2023 Dec; 55(12):1667-1672. PubMed ID: 37517963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia.
    Small AJ; Araujo JL; Leggett CL; Mendelson AH; Agarwalla A; Abrams JA; Lightdale CJ; Wang TC; Iyer PG; Wang KK; Rustgi AK; Ginsberg GG; Forde KA; Gimotty PA; Lewis JD; Falk GW; Bewtra M
    Gastroenterology; 2015 Sep; 149(3):567-76.e3; quiz e13-4. PubMed ID: 25917785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes Following Recurrence of Intestinal Metaplasia After Successful Treatment of Barrett's Esophagus With Radiofrequency Ablation.
    Guthikonda A; Cotton CC; Madanick RD; Spacek MB; Moist SE; Ferrell K; Dellon ES; Shaheen NJ
    Am J Gastroenterol; 2017 Jan; 112(1):87-94. PubMed ID: 27725648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium.
    Gupta M; Iyer PG; Lutzke L; Gorospe EC; Abrams JA; Falk GW; Ginsberg GG; Rustgi AK; Lightdale CJ; Wang TC; Fudman DI; Poneros JM; Wang KK
    Gastroenterology; 2013 Jul; 145(1):79-86.e1. PubMed ID: 23499759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Associated With Recurrence of Barrett's Esophagus After Radiofrequency Ablation.
    Tan MC; Kanthasamy KA; Yeh AG; Kil D; Pompeii L; Yu X; El-Serag HB; Thrift AP
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):65-72.e5. PubMed ID: 29902646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of preceding endoscopic mucosal resection on the efficacy and safety of radiofrequency ablation for treatment of Barrett's esophagus: results from the United States Radiofrequency Ablation Registry.
    Li N; Pasricha S; Bulsiewicz WJ; Pruitt RE; Komanduri S; Wolfsen HC; Chmielewski GW; Corbett FS; Chang KJ; Shaheen NJ
    Dis Esophagus; 2016 Aug; 29(6):537-43. PubMed ID: 26121935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance in Barrett's esophagus: an audit of practice.
    Ajumobi A; Bahjri K; Jackson C; Griffin R
    Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.